Intervention Review

Botulinum toxin type A therapy for blepharospasm

  1. João Costa1,*,
  2. Cláudia C Espírito-Santo1,
  3. Ana A Borges1,
  4. Joaquim Ferreira1,
  5. Miguel M Coelho1,
  6. Peter Moore2,
  7. Cristina Sampaio1

Editorial Group: Cochrane Movement Disorders Group

Published Online: 19 APR 2004

Assessed as up-to-date: 24 DEC 2003

DOI: 10.1002/14651858.CD004900.pub2


How to Cite

Costa J, Espírito-Santo CC, Borges AA, Ferreira J, Coelho MM, Moore P, Sampaio C. Botulinum toxin type A therapy for blepharospasm. Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD004900. DOI: 10.1002/14651858.CD004900.pub2.

Author Information

  1. 1

    Faculdade de Medicina de Lisboa, Laboratório de Farmacologia Clínica e Terapêutica, Lisboa, Portugal

  2. 2

    NHS Trust, The Walton Centre for Neurology and Neurosurgery, Liverpool, UK

*João Costa, Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina de Lisboa, Av. Prof. Egas Moniz, Lisboa, 1649-028, Portugal. joaoncosta@sapo.pt. joaoncosta@sapo.pt.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 APR 2004

SEARCH

  1. Current Version

    Botulinum toxin type A therapy for blepharospasm

    João Costa, Cláudia C Espírito-Santo, Ana A Borges, Joaquim Ferreira, Miguel M Coelho, Peter Moore and Cristina Sampaio

    Article first published online: 19 APR 2004 | DOI: 10.1002/14651858.CD004900.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Botulinum toxin type A therapy for blepharospasm

    J Costa, JJ Ferreira, M Coelho, A Borges, C Espírito-Santo, P Moore and C Sampaio

    Article first published online: 19 JUL 2004 | DOI: 10.1002/14651858.CD004900